Medical devices, healthcare technology and the business of care
510(k) clearance · K261648

Evident Vascular Guidance System

Evident Vascular, Inc. · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONK261648

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on October 28, 2026 for K261648, the Evident Vascular™ Guidance System submitted by Evident Vascular, Inc. of San Jose, California. This is a traditional 510(k) clearance, not a PMA approval. The system is classified under 21 CFR 892.1560 as an ultrasonic pulsed echo imaging system, Class II, with primary product code IYO and subsequent codes OBJ and ITX; the regulation medical specialty is Radiology and the review panel is Cardiovascular.

The submission describes a console with a workstation, catheter interface module, tablet-based user interface and single-use intravascular ultrasound catheters, offered in mobile cart and integrated laboratory configurations. The summary names the iLab Polaris Multi-Modality Guidance System (K210889) as predicate and cites OptiCross 18 Peripheral Imaging Catheters (K222568, K200733) as reference devices. Stated indications cover ultrasound examination of intravascular pathology in candidates for transluminal interventional procedures, with peripheral imaging catheters limited to peripheral vascular pathology. The record does not include clinical performance data, so comparative imaging performance is unverified here.

The database lists a receipt date of 05/18/2026, while the summary letter is dated September 28, 2026; the discrepancy is unexplained in the available text.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 28, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261648
Regulatory pathway
510(k) premarket notification
Product code
IYO
Decision code
SESE
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Echo, Ultrasonic.

Product code
IYO
FDA device class
2

FDA decision timeline

  1. K261648 received

    Application receipt date recorded by FDA.

  2. K261648 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYO

Product / regulatory recordCompanyPathwayDecision dateSource
Accuro XVK262093
Rivanna Medical, Inc.510(k) clearanceOct 20, 2026FDA
Lilium Otsuka Co., Ltd.510(k) clearanceOct 16, 2026FDA
MEDA Co., Ltd.510(k) clearanceSep 24, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Evident Vascular, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
San Jose, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records